Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis

Am J Kidney Dis. 2021 Nov;78(5):766-768. doi: 10.1053/j.ajkd.2021.07.004. Epub 2021 Aug 6.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged, 80 and over
  • Antibodies / blood*
  • BNT162 Vaccine
  • Belgium / epidemiology
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / immunology
  • COVID-19* / epidemiology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Cohort Studies
  • Female
  • Homes for the Aged / statistics & numerical data
  • Humans
  • Immunogenicity, Vaccine / immunology*
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / immunology
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / immunology
  • Male
  • Nursing Homes / statistics & numerical data
  • Renal Dialysis / methods
  • Renal Dialysis / statistics & numerical data
  • SARS-CoV-2 / physiology
  • Spike Glycoprotein, Coronavirus / immunology*

Substances

  • Antibodies
  • COVID-19 Vaccines
  • Immunologic Factors
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • BNT162 Vaccine